BIG Pharma has a bad global reputation for greed and dirty tricks, but the firm and dignified posture adopted by AstroZeneca – and especially its chief executive, the Frenchman Pascal Soriot – under extreme bullying pressure from the European Union, has been exemplary.
No comments
To be able to write a comment, you have to be registered and logged in
Currently there are no comments.